Strides Arcolab wins FDA approval for India facility

- Last updated on GMT

Strides Arcolab wins FDA approval for India facility
Strides Arcolab announced Friday that its oral dosage manufacturing site in Bangalore, India, was recently approved by the US FDA following a GMP compliance audit. 

The last FDA inspection and approval of the facility -- which manufactures oral dosage forms such as tablets, capsules and sachet -- was in 2011. Strides has four other facilities with which it provides treatments for more than 75 countries.

The approval comes as Strides is still dealing with a Form 483 the company received​ from the FDA back in August for its injectables facility.

That letter cited the company’s insufficient response to corrective actions, as well as its failure to establish an appropriate monitoring system of environmental conditions. 

Related news

Show more

Related products

show more


Optimizing vessel geometry for mag drive agitators

Steridose, Inc | 14-Sep-2017 | Technical / White Paper

The performance of a bottom mount magnetically driven agitator (mag drive mixer) is heavily dependent on its relationship with the vessel’s geometry, baffles,...

Related suppliers